Heptyl prodigiosin from estuarine Zooshikella sp. RANM57 induces caspase-dependent apoptosis and suppresses clonogenic survival in androgen-independent prostate cancer cells

The ocean floor and the muddy edges where rivers meet the sea are not just habitats for fish and crabs; they are vast, hidden chemical factories. For decades, scientists have looked to these environments to find new medicines, particularly for treating diseases like cancer that are difficult to cure. Nature has long provided the blueprints for powerful drugs, from the first antibiotics to modern chemotherapy agents. The logic is simple: organisms that live in extreme or changing conditions often evolve unique ways to survive, producing complex chemicals that can disrupt the growth of other living things. Researchers are now turning their attention to the microscopic life in estuaries, where fresh and salt water mix. These zones are stressful places for bacteria, forcing them to develop specialized tools, some of which might hold the key to stopping human cells from growing out of control.

In this context, a team of researchers from universities in India set out to explore the potential of a specific bacterium found in the Netravathi River estuary in Mangalore. They were interested in a strain of bacteria called Zooshikella sp. RANM57, which produces a striking red pigment. While many bacteria make colors, this particular red substance belongs to a family of compounds known for their ability to kill other cells. The scientists wanted to know if this specific pigment, produced by their unique estuarine bacteria, could be a new weapon against prostate cancer, a disease that often becomes resistant to standard treatments as it progresses.

The researchers began by growing large amounts of the red-pigmented bacteria in a lab setting, mimicking the conditions of the river estuary where it was found. Once the bacteria had multiplied, they harvested the cells and used a series of chemical steps to extract the red pigment. This process involved separating the pigment from the rest of the bacterial material using solvents and then purifying it through a technique that acts like a very fine filter, isolating the single most active ingredient. The result was a small amount of a pure, red substance. To understand exactly what they had found, the team used advanced machines that measure the weight of molecules and the way atoms are arranged. These tools confirmed that the substance was a specific type of molecule called heptyl prodigiosin. This molecule is built from three linked rings of carbon and nitrogen, with a long chain of carbon atoms attached to it, a structure that helps it slip easily into cell membranes.

With the molecule identified, the team moved to test its power against human cancer cells. They chose a specific type of prostate cancer cell line known as PC-3, which is difficult to treat because it does not rely on male hormones to grow, making it resistant to many common therapies. When they exposed these cancer cells to the purified red pigment, the cells began to die. The researchers measured how much of the substance was needed to kill half of the cells in a dish. They found that heptyl prodigiosin was effective at a concentration of 9.00 micrograms per milliliter. For comparison, they tested a standard chemotherapy drug called cisplatin under the same conditions. The pigment worked at a much lower concentration than the standard drug, suggesting it was highly potent against this specific type of cancer cell. They also tested the substance on normal, healthy lung cells to see if it was too toxic for the body. While it did affect the healthy cells, it required a higher concentration to do so, indicating that it might be more dangerous to the cancer cells than to normal tissue, though it is not perfectly selective.

To understand how the pigment killed the cancer cells, the scientists looked closely at what was happening inside them. They discovered that the cells were not simply bursting open or rotting, which is a chaotic form of cell death called necrosis. Instead, the cells were undergoing a controlled, programmed self-destruction known as apoptosis. This is a natural process the body uses to remove damaged or unwanted cells, but cancer cells often learn to ignore these signals. The researchers observed that the red pigment forced the cancer cells to restart this self-destruct sequence. They saw clear signs that the outer layer of the cells was changing, a signal that usually happens early in the death process. Further tests showed that the cells were activating specific enzymes, known as caspases, which act as the executioners of the cell, cutting up the cell's internal machinery. Finally, they found that the DNA inside the cells, which holds the genetic instructions, was being fragmented and broken apart. This chain of events confirmed that the pigment was not just poisoning the cells, but was triggering a precise biological mechanism to eliminate them.

The study also looked at the long-term ability of these cancer cells to reproduce. Even after the cells were treated with the pigment and then placed in fresh food, they struggled to grow back into large colonies. This suggests that the treatment did not just stop the cells from growing for a moment, but damaged them enough that they could not recover and multiply over time. While the pigment was effective, the researchers noted that it did not kill as many cells in the long run as the standard drug cisplatin did in their specific tests, even though it was more potent at stopping initial growth. This highlights that different tests measure different aspects of a drug's power.

The researchers were careful to point out the limits of their work. They confirmed the identity of the molecule using strong evidence, but they did not perform every possible test to map out every single step of how it works inside the cell. They also noted that because the substance is a bright red pigment, it can sometimes interfere with the machines used to measure cell death, so the results need to be interpreted with that in mind. Furthermore, while the substance showed promise against one type of cancer cell, it was not tested on a wide variety of other cancers or in living animals. The study establishes that this estuarine bacterium produces a potent compound that can trigger cell death in prostate cancer, but it is a starting point. The work proves that the muddy edges of rivers are still a rich source of new chemical tools, and that heptyl prodigiosin is a candidate worthy of further study to see if it can be developed into a real treatment for patients.